Skip to main content
Equibles

MetLife Investment Management, LLC

Position in NEO — Neogenomics Inc

CIK 1529735 Whippany, NJ
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,120,293
+$635,656 QoQ
Shares Held
76,785
+17.6% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $164,155,372 across 29 Diagnostics & Research names. NEO ranks #19 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 85,023 $42,627,131
2 DHR
Danaher Corp /De/
 144,142 $27,456,168
3 ILMN
Illumina, Inc.
 72,858 $12,810,622
4 IDXX
Idexx Laboratories Inc /De
 20,659 $10,875,723
5 A
Agilent Technologies, Inc.
 64,648 $8,587,193
6 WAT
Waters Corp /De/
 22,466 $8,425,648
7 IQV
Iqvia Holdings Inc.
 38,172 $7,375,593
8 MEDP
Medpace Holdings, Inc.
 11,779 $6,238,040

All Filings in NEO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,120,293 76,785
2026-03-31 $484,637 65,315
2025-12-31 $843,591 71,734
2025-09-30 $542,021 70,210
2025-06-30 $557,109 76,212
2025-03-31 $723,251 76,212
2024-12-31 $1,275,601 77,403
2024-09-30 $1,103,403 74,807
2024-06-30 $1,037,573 74,807
2024-03-31 $1,058,616 67,342
2023-12-31 $1,089,593 67,342
2023-09-30 $828,306 67,342
2023-06-30 $1,082,185 67,342
2023-03-31 $1,156,650 66,436
2022-12-31 $613,868 66,436
2022-09-30 $562,336 65,312
2022-06-30 $501,298 61,509
2022-03-31 $747,334 61,509
2021-12-31 $1,333,580 39,085
2021-09-30 $1,885,460 39,085
2021-06-30 $1,843,749 40,818
2021-03-31 $1,968,652 40,818
2020-12-31 $2,299,775 42,715
2020-09-30 $1,688,639 45,775
2020-06-30 $1,418,109 45,775
2020-03-31 $1,100,617 39,863